← Back to Clinical Trials
Recruiting NCT05606562

NCT05606562 Drug-free Without Toothache. A Study of Free Dental Treatment as a Part of Substance Abuse Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05606562
Status Recruiting
Phase
Sponsor University Hospital of North Norway
Condition Substance Abuse
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2022-04-06
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Dental care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2022-04-06 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Objectives: The main objective of the study is to investigate 1. How many patients will attend and complete dental care if they are offered it for free during the stay at "The department of substance abuse treatment, University Hospital North Norway (UNN) in Narvik". 2. Explore whether a parallel dental treatment in addition to the other treatment at the department has a beneficial effect on the abuse treatment, or whether it can be disruptive to offer dental treatment in combination with admission for drug rehabilitation?

Eligibility Criteria

Inclusion Criteria: People who are hospitalized for drug abuse at Russeksjon UNN Narvik. Exclusion Criteria: Non

Contact & Investigator

Central Contact

Stian Anthonsen, MD

✉ andreas.holund@unn.no

📞 97710986

Principal Investigator

Merethe Kumle, MD, PhD

PRINCIPAL INVESTIGATOR

University Hospital of North Norway

Frequently Asked Questions

Who can join the NCT05606562 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05606562 currently recruiting?

Yes, NCT05606562 is actively recruiting participants. Contact the research team at andreas.holund@unn.no for enrollment information.

Where is the NCT05606562 trial being conducted?

This trial is being conducted at Narvik, Norway.

Who is sponsoring the NCT05606562 clinical trial?

NCT05606562 is sponsored by University Hospital of North Norway. The principal investigator is Merethe Kumle, MD, PhD at University Hospital of North Norway. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology